Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-22T02:09:16.128Z Has data issue: false hasContentIssue false

P0149 - Fulfillment, satisfaction and functioning in patients hospitalized with bipolar disorder and treatment with Depakine Crono

Published online by Cambridge University Press:  16 April 2020

M. Serrano Vazquez
Affiliation:
Psychiatry Service of Juan Canalejo Hospital, A Coruna, Spain
M.C. Serrano Carton
Affiliation:
Psychiatry Service of Juan Canalejo Hospital, A Coruna, Spain
M.M. Serrano Carton
Affiliation:
Psychiatry Service of Juan Canalejo Hospital, A Coruna, Spain
M.J. Avila Gonzalez
Affiliation:
Psychiatry Service of Juan Canalejo Hospital, A Coruna, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Depakine crono presents an immediate, longer absorption, with maximum plasmatic concentrations less high than the classic one. It allows a minor number of doses and a better therapeutic fulfillment.

Aims:

To identify the characteristics and the patients profile treated with depakine crono in a unit of hospitalization. Patients had the diagnosis of bipolar or schizoaffective disorder and they were followed out of the hospital. We stand out the clinical improvement, level of satisfaction, adherence, fulfilment and quality of life obtained.

Methods:

Patients with a descompensation of their affective disorder admitted in a Acute Unite were studied (N=30). They all needed depakine crono for their stabilization.The information has been obtained by a interview, applying a specific protocol with demographic and clinical data, exploring the reasons and satisfaction with the medication. Four clinical scales were used: DAI, the Scale of Disability of the OMS, EEAG and ICG for the Bipolar Disorder.

Conclusions:

The profile showed an 32-48-year-old, married woman, with primary studies who lived in family environment, with a maniac episode, with a development of the disease of more than 20 year. The age of the first episode was of 21 years, with somatic and personality disorders and abuse of substances.

The clinical impression in the admission is serious. The average dose needed of depakine crono was 1.000 mg/día, with a good efficiency in the most of patients. The personal and labour functionality improve from the beginning of the treatment. The level of therapeutic fulfillment is satisfactory.

Type
Poster Session II: Bipolar Disorders
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.